These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38062516)

  • 1. M-type pyruvate kinase 2 (PKM2) tetramerization alleviates the progression of right ventricle failure by regulating oxidative stress and mitochondrial dynamics.
    Guo L; Wang L; Qin G; Zhang J; Peng J; Li L; Chen X; Wang D; Qiu J; Wang E
    J Transl Med; 2023 Dec; 21(1):888. PubMed ID: 38062516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage-NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension.
    Al-Qazazi R; Lima PDA; Prisco SZ; Potus F; Dasgupta A; Chen KH; Tian L; Bentley RET; Mewburn J; Martin AY; Wu D; Jones O; Maurice DH; Bonnet S; Provencher S; Prins KW; Archer SL
    Am J Respir Crit Care Med; 2022 Sep; 206(5):608-624. PubMed ID: 35699679
    [No Abstract]   [Full Text] [Related]  

  • 3. Shikonin improves pulmonary vascular remodeling in monocrotaline‑induced pulmonary arterial hypertension via regulation of PKM2.
    Li W; Chen W; Peng H; Xiao Z; Liu J; Zeng Y; Huang T; Song Q; Wang X; Xiao Y
    Mol Med Rep; 2023 Mar; 27(3):. PubMed ID: 36734266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic Metabolic Reprogramming of Right Ventricular Fibroblasts in Pulmonary Arterial Hypertension: A Pyruvate Dehydrogenase Kinase-Dependent Shift in Mitochondrial Metabolism Promotes Right Ventricular Fibrosis.
    Tian L; Wu D; Dasgupta A; Chen KH; Mewburn J; Potus F; Lima PDA; Hong Z; Zhao YY; Hindmarch CCT; Kutty S; Provencher S; Bonnet S; Sutendra G; Archer SL
    Circ Res; 2020 Jun; 126(12):1723-1745. PubMed ID: 32216531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to the development of pulmonary arterial hypertension.
    Guo D; Gu J; Jiang H; Ahmed A; Zhang Z; Gu Y
    J Mol Cell Cardiol; 2016 Feb; 91():179-87. PubMed ID: 26774701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biventricular Increases in Mitochondrial Fission Mediator (MiD51) and Proglycolytic Pyruvate Kinase (PKM2) Isoform in Experimental Group 2 Pulmonary Hypertension-Novel Mitochondrial Abnormalities.
    Xiong PY; Tian L; Dunham-Snary KJ; Chen KH; Mewburn JD; Neuber-Hess M; Martin A; Dasgupta A; Potus F; Archer SL
    Front Cardiovasc Med; 2018; 5():195. PubMed ID: 30740395
    [No Abstract]   [Full Text] [Related]  

  • 7. Betaine alleviates right ventricular failure via regulation of Rho A/ROCK signaling pathway in rats with pulmonary arterial hypertension.
    Lv Y; Ma P; Wang J; Xu Q; Fan J; Yan L; Ma P; Zhou R
    Eur J Pharmacol; 2021 Nov; 910():174311. PubMed ID: 34245749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of right ventricular remodeling by dichloroacetate is related to inhibition of mitochondria-dependent apoptosis.
    Sun XQ; Zhang R; Zhang HD; Yuan P; Wang XJ; Zhao QH; Wang L; Jiang R; Jan Bogaard H; Jing ZC
    Hypertens Res; 2016 May; 39(5):302-11. PubMed ID: 26763846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Intervention of Tongxinluo () on Right Ventricular Function Assessed by Echocardiography in Rats with Pulmonary Arterial Hypertension Induced by Monocrotaline.
    Gao L; Li SD; Zhang Y; Liu Y; Yang MH
    Chin J Integr Med; 2020 Dec; 26(12):913-920. PubMed ID: 32418178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
    Balestra GM; Mik EG; Eerbeek O; Specht PA; van der Laarse WJ; Zuurbier CJ
    Respir Res; 2015 Feb; 16(1):6. PubMed ID: 25645252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sildenafil prevents and reverses transverse-tubule remodeling and Ca(2+) handling dysfunction in right ventricle failure induced by pulmonary artery hypertension.
    Xie YP; Chen B; Sanders P; Guo A; Li Y; Zimmerman K; Wang LC; Weiss RM; Grumbach IM; Anderson ME; Song LS
    Hypertension; 2012 Feb; 59(2):355-62. PubMed ID: 22203744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibiting pyruvate kinase muscle isoform 2 regresses group 2 pulmonary hypertension induced by supra-coronary aortic banding.
    Xiong PY; Motamed M; Chen KH; Dasgupta A; Potus F; Tian L; Martin A; Mewburn J; Jones O; Thébaud A; Archer SL
    Acta Physiol (Oxf); 2022 Feb; 234(2):e13764. PubMed ID: 34978755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PARP1-PKM2 Axis Mediates Right Ventricular Failure Associated With Pulmonary Arterial Hypertension.
    Shimauchi T; Boucherat O; Yokokawa T; Grobs Y; Wu W; Orcholski M; Martineau S; Omura J; Tremblay E; Shimauchi K; Nadeau V; Breuils-Bonnet S; Paulin R; Potus F; Provencher S; Bonnet S
    JACC Basic Transl Sci; 2022 Apr; 7(4):384-403. PubMed ID: 35540097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of hexokinase1 in the right ventricle of monocrotaline induced pulmonary hypertension.
    Zhang WH; Qiu MH; Wang XJ; Sun K; Zheng Y; Jing ZC
    Respir Res; 2014 Oct; 15(1):119. PubMed ID: 25287584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyruvate kinase M2 sustains cardiac mitochondrial integrity in septic cardiomyopathy by regulating PHB2-dependent mitochondrial biogenesis.
    Ren J; Ren B; Fu T; Ma Y; Tan Y; Zhang S; Li Y; Wang Q; Chang X; Tong Y
    Int J Med Sci; 2024; 21(6):983-993. PubMed ID: 38774750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic carvedilol treatment partially reverses the right ventricular failure transcriptional profile in experimental pulmonary hypertension.
    Drake JI; Gomez-Arroyo J; Dumur CI; Kraskauskas D; Natarajan R; Bogaard HJ; Fawcett P; Voelkel NF
    Physiol Genomics; 2013 Jun; 45(12):449-61. PubMed ID: 23632417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PKM2 promotes angiotensin-II-induced cardiac remodelling by activating TGF-β/Smad2/3 and Jak2/Stat3 pathways through oxidative stress.
    Zhang X; Zheng C; Gao Z; Wang L; Chen C; Zheng Y; Meng Y
    J Cell Mol Med; 2021 Nov; 25(22):10711-10723. PubMed ID: 34687136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyruvate Kinase M2 Protects Heart from Pressure Overload-Induced Heart Failure by Phosphorylating RAC1.
    Ni L; Lin B; Hu L; Zhang R; Fu F; Shen M; Yang J; Shi D
    J Am Heart Assoc; 2022 Jun; 11(11):e024854. PubMed ID: 35656980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical symptoms of right ventricular failure in experimental chronic pressure load are associated with progressive diastolic dysfunction.
    Borgdorff MA; Koop AM; Bloks VW; Dickinson MG; Steendijk P; Sillje HH; van Wiechen MP; Berger RM; Bartelds B
    J Mol Cell Cardiol; 2015 Feb; 79():244-53. PubMed ID: 25486580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure.
    Piao L; Marsboom G; Archer SL
    J Mol Med (Berl); 2010 Oct; 88(10):1011-20. PubMed ID: 20820751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.